A potential downstream platform approach for WuXiBody-based IgG-like bispecific antibodies.
Sign Up to like & getrecommendations! Published in 2020 at "Protein expression and purification"
DOI: 10.1016/j.pep.2020.105647
Abstract: WuXiBody is a novel bispecific antibody (bsAb) platform developed by WuXi Biologics. It enables almost any monoclonal antibody (mAb) sequence pair to be assembled into a bispecific construct. BsAbs based on WuXiBody can adopt either… read more here.
Keywords: platform approach; approach wuxibody; platform; wuxibody based ... See more keywords